Related references
Note: Only part of the references are listed.Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4
Jing Xing et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Drug Discovery Targeting Bromodomain-Containing Protein 4
Zhiqing Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors
Wei-yao Zhang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays
Zhongya Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
8-Hydroxyquinolines in medicinal chemistry: A structural perspective
Valentina Oliveri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation
Xiaoqian Xue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1)
Martin Huegle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
Brian K. Albrecht et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting BET bromodomains for cancer treatment
Marie Jung et al.
EPIGENOMICS (2015)
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
Lei-lei Fu et al.
ONCOTARGET (2015)
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
Bojana Mirkovic et al.
ONCOTARGET (2015)
Nitroxoline induces apoptosis and slows glioma growth in vivo
Jelena Lazovic et al.
NEURO-ONCOLOGY (2015)
Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections
Kurt G. Naber et al.
BMC INFECTIOUS DISEASES (2014)
Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Friederike Itzen et al.
NUCLEIC ACIDS RESEARCH (2014)
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Sarah Picaud et al.
CANCER RESEARCH (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
The bromodomain interaction module
Panagis Filippakopoulos et al.
FEBS LETTERS (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline)
Hongchao Jiang et al.
CANCER LETTERS (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds
Bojana Mirkovic et al.
CHEMMEDCHEM (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain
Takashi Umehara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer
Joong Sup Shim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis
Poonpilas Hongmanee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p
DJ Owen et al.
EMBO JOURNAL (2000)
Share Paper
